CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | Hippel James CFO | Option exercise · Stock Options (Right to Buy) | −62,000 | 62,068 | ||
| 2026-05-05 | Bohnen Shane SVP - General Counsel | Option exercise | +8,400 | $47.60 | $400K | 14,304 |
| 2026-05-05 | Bohnen Shane SVP - General Counsel | Shares withheld for taxes | −7,055 | $56.68 | $400K | 7,249 |
| 2026-05-05 | Bohnen Shane SVP - General Counsel | Option exercise · Stock Option (Right to Buy) | −8,400 | 448 | ||
| 2026-05-05 | Kelderman Kim Chief Executive Officer | Option exercise | +26,692 | $47.60 | $1.3M | 89,750 |
| 2026-05-05 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −23,951 | $56.68 | $1.4M | 65,799 |
| 2026-05-05 | Kelderman Kim Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −26,692 | 35,000 | ||
| 2026-05-01 | Crouse Steven C. President - Diag & Spatial Bi | Option exercise | +794 | 6,688 | ||
| 2026-05-01 | Crouse Steven C. President - Diag & Spatial Bi | Shares withheld for taxes | −311 | $55.02 | $17K | 6,337 |
| 2026-05-01 | Crouse Steven C. President - Diag & Spatial Bi | Option exercise · Restricted Stock Units | −794 | 794 | ||
| 2026-04-22 | Kelderman Kim Chief Executive Officer | Option exercise | +11,344 | 64,421 | ||
| 2026-04-22 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −1,363 | $58.58 | $80K | 63,058 |
| 2026-04-22 | Kelderman Kim Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −11,344 | 61,692 | ||
| 2026-04-22 | Hippel James CFO | Option exercise | +62,000 | 204,722 | ||
| 2026-04-22 | Hippel James CFO | Shares withheld for taxes | −56,097 | $58.58 | $3.3M | 148,625 |
| 2026-04-22 | Hippel James CFO | Option exercise · Stock Options (Right to Buy) | −62,000 | 124,068 | ||
| 2026-04-14 | Kelderman Kim Chief Executive Officer | Option exercise | +36,500 | 85,165 | ||
| 2026-04-14 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −32,088 | $58.66 | $1.9M | 53,077 |
| 2026-04-14 | Kelderman Kim Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −36,500 | 73,036 | ||
| 2026-04-03 | Bohnen Shane SVP - General Counsel | Option exercise | +2,259 | 6,644 |
Page 7 of 32 · 626 trades